IRIDEX (IRIX) Competitors $1.04 -0.01 (-0.95%) Closing price 10/17/2025 03:50 PM EasternExtended Trading$1.06 +0.02 (+1.83%) As of 10/17/2025 05:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock IRIX vs. GUTS, LUNG, ICCM, DXR, MDAI, QTI, TELA, CTSO, BDMD, and SURGShould you be buying IRIDEX stock or one of its competitors? The main competitors of IRIDEX include Fractyl Health (GUTS), Pulmonx (LUNG), IceCure Medical (ICCM), Daxor (DXR), Spectral AI (MDAI), QT Imaging (QTI), TELA Bio (TELA), Cytosorbents (CTSO), Baird Medical Investment (BDMD), and SurgePays (SURG). These companies are all part of the "medical equipment" industry. IRIDEX vs. Its Competitors Fractyl Health Pulmonx IceCure Medical Daxor Spectral AI QT Imaging TELA Bio Cytosorbents Baird Medical Investment SurgePays IRIDEX (NASDAQ:IRIX) and Fractyl Health (NASDAQ:GUTS) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, media sentiment, earnings, dividends and institutional ownership. Do analysts rate IRIX or GUTS? Fractyl Health has a consensus target price of $6.90, indicating a potential upside of 434.88%. Given Fractyl Health's stronger consensus rating and higher possible upside, analysts plainly believe Fractyl Health is more favorable than IRIDEX.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IRIDEX 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Fractyl Health 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60 Which has stronger earnings and valuation, IRIX or GUTS? IRIDEX has higher revenue and earnings than Fractyl Health. IRIDEX is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIRIDEX$48.67M0.36-$8.91M-$0.33-3.15Fractyl Health$90K720.82-$68.69M-$2.06-0.63 Do institutionals & insiders have more ownership in IRIX or GUTS? 20.1% of IRIDEX shares are owned by institutional investors. 7.4% of IRIDEX shares are owned by insiders. Comparatively, 26.1% of Fractyl Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media refer more to IRIX or GUTS? In the previous week, Fractyl Health had 2 more articles in the media than IRIDEX. MarketBeat recorded 3 mentions for Fractyl Health and 1 mentions for IRIDEX. Fractyl Health's average media sentiment score of 0.32 beat IRIDEX's score of 0.00 indicating that Fractyl Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IRIDEX 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Fractyl Health 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk and volatility, IRIX or GUTS? IRIDEX has a beta of 0.59, indicating that its share price is 41% less volatile than the S&P 500. Comparatively, Fractyl Health has a beta of 2.27, indicating that its share price is 127% more volatile than the S&P 500. Is IRIX or GUTS more profitable? Fractyl Health has a net margin of 0.00% compared to IRIDEX's net margin of -10.95%. IRIDEX's return on equity of -386.93% beat Fractyl Health's return on equity.Company Net Margins Return on Equity Return on Assets IRIDEX-10.95% -386.93% -17.42% Fractyl Health N/A -584.35%-102.88% SummaryFractyl Health beats IRIDEX on 10 of the 16 factors compared between the two stocks. Get IRIDEX News Delivered to You Automatically Sign up to receive the latest news and ratings for IRIX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IRIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRIX vs. The Competition Export to ExcelMetricIRIDEXLASERS IndustryComputer SectorNASDAQ ExchangeMarket Cap$17.67M$1.09B$32.72B$10.55BDividend YieldN/AN/A3.22%4.83%P/E Ratio-3.15N/A479.2827.06Price / Sales0.3660.611,480.84132.30Price / CashN/A29.0134.6830.35Price / Book8.005.047.426.58Net Income-$8.91M-$60.02M$820.47M$276.84M7 Day Performance-0.48%-1.75%-1.17%-0.72%1 Month Performance-12.61%-5.20%1.03%2.16%1 Year Performance-36.59%9.45%24,183.57%34.63% IRIDEX Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRIXIRIDEX0.4537 of 5 stars$1.04-1.0%N/A-36.6%$17.67M$48.67M-3.15120News CoverageGap UpGUTSFractyl Health2.8025 of 5 stars$1.49+1.4%$6.90+362.8%-48.2%$75.18M$17K-0.73102Short Interest ↑High Trading VolumeLUNGPulmonx3.9899 of 5 stars$1.74flat$7.66+340.5%-76.6%$71.10M$90.55M-1.22250ICCMIceCure Medical2.1948 of 5 stars$0.99-1.5%$2.64+167.5%+52.4%$67.67M$3.29M-6.1660DXRDaxor3.2796 of 5 stars$13.50-2.2%$25.00+85.2%+41.8%$65.30M$3.31M0.0037Positive NewsMDAISpectral AI1.6258 of 5 stars$2.43+0.2%$3.50+44.3%+94.3%$64.85M$27.55M-3.5283QTIQT ImagingN/A$2.33+0.1%N/A+239.1%$63.26M$4.00M0.00N/APositive NewsTELATELA Bio2.1814 of 5 stars$1.59+5.0%$4.50+183.0%-39.5%$63.00M$69.30M-1.42120CTSOCytosorbents1.7004 of 5 stars$0.99+4.8%$5.50+458.4%-18.8%$61.76M$35.60M-5.79220BDMDBaird Medical InvestmentN/A$1.71+2.4%N/A-49.7%$61.10MN/A0.00N/AShort Interest ↑SURGSurgePays2.0804 of 5 stars$2.83-1.6%$9.50+236.3%+46.0%$57.69M$60.88M-1.1340 Related Companies and Tools Related Companies GUTS Alternatives LUNG Alternatives ICCM Alternatives DXR Alternatives MDAI Alternatives QTI Alternatives TELA Alternatives CTSO Alternatives BDMD Alternatives SURG Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IRIX) was last updated on 10/20/2025 by MarketBeat.com Staff From Our PartnersGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredThis Crypto Is Set to Explode in JanuaryCurious about crypto but still stuck scrolling endless threads? People who get in early aren’t just lucky—they...Crypto 101 Media | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IRIDEX Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share IRIDEX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
